Categories
Change Password!
Reset Password!
Short-term nimesulide use demonstrates good tolera...
Taking NSAIDs after 60? Study warns of increased G...
A large hospital-based study from Beijing has identified significant risk factors associated with nonsteroidal anti-inflammatory drug (NSAID)-ind...
Rabeprazole emerges as preferred PPI for GERD pati...
Tackling gastroesophageal reflux disease (GERD) in patients with multiple comorbidities and concurrent medications remains a clinical challenge,...
Low-dose aspirin raises gastric and duodenal ulcer...
A large population-based analysis of over 220,000 volunteers has revealed that low-dose aspirin initiation is connected with increased risk of ga...
Tegoprazan emerges as fast-acting alternative to P...
A large study has positioned tegoprazan, a potassium-competitive acid blocker (PCAB), as a next-generation therapy for gastroesophageal reflux di...
Long-term intramuscular cyanocobalamin therapy in...
Corpus atrophic gastritis (CAG) is a chronic autoimmune condition characterized by progressive loss of gastric acid secretion and intrinsic facto...
Global PPI use hits 25%: Study flags rising long-t...
A large-scale systematic review assessing global trends in proton pump inhibitor (PPI) use has revealed that these acid-suppressing drugs are use...
IBS and lifestyle factors: How stress, sleep, and...
Affecting roughly 10% of people worldwide, irritable bowel syndrome (IBS) is a functional gastrointestinal (GI) condition characterized by persis...
High-dose vs. conventional therapy for H. pylori e...
Optimizing Helicobacter pylori (H. pylori) eradication therapy is fundamental in the era of rising antibiotic resistance.
Diagnosis and Management of GERD: Updates from Lyo...
Gastroesophageal reflux disease (GERD) is one of the most common gastrointestinal ailments globally, impacting approximately 1.03 billion individ...
